Matthew Shen

AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis

Bryna S.M. Chow, Martina Kočan, Matthew Shen et al. · Journal of the American Society of Nephrology · 2019 · 50 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +14

Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease

Simon G. Royce, Matthew Shen, Krupesh P. Patel et al. · Stem Cell Research · 2015 · 41 citations · Full text

Life Sciences, Cell Biology, Pathobiology +17

Serelaxin and the AT₂ Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan Cilexetil

Yan Wang, Lei Han, Matthew Shen et al. · ACS Pharmacology & Translational Science · 2020 · 24 citations · Full text

Medicine, Cardiology, Pharmacology +16

Assessment of renal fibrosis and anti‐fibrotic agents using a novel diagnostic and stain‐free second‐harmonic generation platform

Sadman Bhuiyan, Matthew Shen, Sharenya Chelvaretnam et al. · The FASEB Journal · 2021 · 23 citations

Medicine, Pathology, Urology +16

Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt‐induced hypertension

Yifang Li, Matthew Shen, Dorota Ferens et al. · British Journal of Pharmacology · 2021 · 19 citations · Full text

Medicine, Nephrology, Pharmacology +17